Levetiracetam Tablet
Product Images NDC 69102-106

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 69102-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Owp Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000 mg (120)

This is a prescription medication called Roweepra. It contains 1000mg of evetiracetam USP per tablet. It should be stored in a tight and light-resistant container with a child-resistant closure. The prescribing information will contain dosage recommendations. It is important to dispense the medication guide to the patient. It has a manufacturing license number and a product code. This medicine should be dispensed after verification. Store this medicine between 20-26°C, with excursions allowed between 15-30°C (59°-86°F).*

FDA Label Image

1000 mg (60)

This appears to be a description of medication in tablet form called Levitiracetam, with a recommended dosage of 1000mg. A medication guide is also mentioned that should be dispensed to each patient. The packaging includes 60 tablets and is manufactured by a company called Rev202018. There is also a reference number provided. The first line mentions an unvarnished area, but it is unclear what this refers to in relation to the medication.*

FDA Label Image

250 mg (Roweepra 250mg)

FDA Label Image

500 mg (Roweepra 500mg)

This is a description of a medication called Roweepra, specifically the 500mg Levetiracetam tablets. The medication is produced by pharmaceutical companies, W Farma and Torrent Pharmaceuticals. The tablets come in a container that is resistant to light and moisture. The prescription information should be given to each patient who takes the medication. It is recommended to store this medication at room temperature, between 20-25°C (88-77°F).*

FDA Label Image

750 mg (Roweepra 750mg)

Product Name: Unvarnished Quantity: 120 tablets Dosage: 750mg Active Ingredient: Levetiracetom tablets USP Caution: Verify product dispensed carefully. Dispense the accompanying modification guide to each patient, Rx only.*

FDA Label Image

Image (Torrent)

FDA Label Image

Fig 1 (Fig 1)

FDA Label Image

Fig 2 (Fig 2)

This is a table showing the percentage of patients who were given Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The number of patients for each group is also mentioned.*

FDA Label Image

Fig 3 (Fig 3)

FDA Label Image

Fig 4 (Fig 4)

This is a table showing various percentages for patients in a clinical trial for a drug called Levetiracetam versus a placebo. The table displays percentages in increments of 5% ranging from 20% to 45% for an unknown metric related to the patients. Additionally, there is a mention of the number of patients in the placebo and Levetiracetam groups, which are 97 and 101 respectively. There are also some non-readable characters such as "@", "%" and "®".*

FDA Label Image

Fig 5 (Fig 5)

This is not-available as the given text does not have sufficient information to generate a useful description. The text contains only some numbers and names of treatments which cannot be interpreted without additional context.*

FDA Label Image

Fig 6 (Fig 6)

This text shows the percentage 45.2% with no clear indication of its meaning. It also shows two groups, one with a sample size of 1 labeled as Placebo and another with a sample size of 79 labeled as Levetiracetam. There is not enough information to determine the context of this text.*

FDA Label Image

Str (Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.